Cardiogenic shock (CS) is a life-threatening condition leading to poor prognosis ... Furthermore, the availability of advance therapies, including mechanical support offer valuable options for infarct ...
Physicians have a new treatment option for many of the sickest pediatric patients with heart failure and cardiogenic shock. Johnson & Johnson MedTech, the global leader in heart recovery, announced ...
Impella 5.5 and Impella CP are the first left-sided, minimally invasive temporary mechanical circulatory support options for pediatric patients with symptomatic ADHF and cardiogenic shock Impella ...
In this paper, we introduce a data processing pipeline for cardiogenic shock (CS) prediction from the MIMIC III database ... Such patient stratification could allow us to take pre-emptive measures, ...
Most of the change in stage of cardiogenic shock (CS) occurred within the first 24 hours of presentation ... 62.2% for those from stage D and 59.7% for those who remained in stage E. Mortality and use ...
Implantation of the Impella CP micro-axial flow pump may increase survival at six months among patients with STEMI complicated by cardiogenic shock ... of shock protocols or a "shock team" as a ...
Utah-based Second Heart Assist Inc., has completed the third in a planned series of studies at a leading clinical site in Asuncion, Paraguay, for use of mechanical circulatory support (MCS) for ...